Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of MGMT, TRA2A, RPS6KA2, and U2AF1 Genes in Prostate Cancer Cell Lines

OMICS. 2020 Aug;24(8):505-507. doi: 10.1089/omi.2020.0054. Epub 2020 Jun 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzazepines / pharmacology*
  • Cell Line, Tumor
  • DNA Modification Methylases / genetics*
  • DNA Modification Methylases / metabolism
  • DNA Repair Enzymes / genetics*
  • DNA Repair Enzymes / metabolism
  • Disease Progression
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Jumonji Domain-Containing Histone Demethylases / antagonists & inhibitors*
  • Jumonji Domain-Containing Histone Demethylases / metabolism*
  • Male
  • Prostatic Neoplasms / enzymology
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / metabolism
  • Pyrimidines / pharmacology*
  • RNA-Binding Proteins / genetics*
  • RNA-Binding Proteins / metabolism
  • Ribosomal Protein S6 Kinases, 90-kDa / genetics*
  • Ribosomal Protein S6 Kinases, 90-kDa / metabolism
  • Splicing Factor U2AF / genetics*
  • Splicing Factor U2AF / metabolism
  • Tumor Suppressor Proteins / genetics*
  • Tumor Suppressor Proteins / metabolism

Substances

  • Benzazepines
  • GSK-J4
  • Pyrimidines
  • RNA-Binding Proteins
  • Splicing Factor U2AF
  • TRA2A protein, human
  • Tumor Suppressor Proteins
  • U2AF1 protein, human
  • Jumonji Domain-Containing Histone Demethylases
  • KDM6B protein, human
  • DNA Modification Methylases
  • MGMT protein, human
  • Ribosomal Protein S6 Kinases, 90-kDa
  • ribosomal protein S6 kinase, 90kDa, polypeptide 3
  • DNA Repair Enzymes